Palazestrant is an antiestrogen and antineoplastic agent. Palazestrant can completely inhibit the activity of 17b-estradiol (E2) with IC50 value of 6.4 nM, and inhibit the proliferation of MCF7 and CAMA-1 cells with IC50 value of 1.4-1.6 nM. Palazestrant
Molecular Weight:
449.60
Purity:
98.96
CAS Number:
[2092925-89-6]
Formula:
C28H36FN3O
Target:
Estrogen Receptor/ERR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted